Therapy
Health
Pharmaceutical

Sarepta Therapeutics

1,835

$163.89
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.40 (+0.24%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell SRPT and other stocks, options, ETFs, and crypto commission-free!

About SRPT

Sarepta Therapeutics, Inc. Common Stock (DE), also called Sarepta Therapeutics, is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. Read More The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

CEO
Douglas S. Ingram
Employees
743
Headquarters
Cambridge, Massachusetts
Founded
1980
Market Cap
12.78B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.08M
High Today
$169.38
Low Today
$162.49
Open Price
$163.09
Volume
491.95K
52 Week High
$172.70
52 Week Low
$72.05

Collections

Therapy
Health
Pharmaceutical
Biopharmaceutical
Biotechnology
Technology
US
North America

SRPT News

ReutersJul 2

BRIEF-Sarepta Therapeutics Signs Agreement With Hansa Biopharma For Imlifidase

July 2 (Reuters) - Sarepta Therapeutics Inc: * SAREPTA THERAPEUTICS SIGNS AGREEMENT WITH HANSA BIOPHARMA FOR IMLIFIDASE * SAREPTA THERAPEUTICS INC - SAREPTA O
0

SRPT Earnings

-$1.86
-$1.24
-$0.62
-$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Aug 5, After Hours

You May Also Like

FLCO
CRIS
FLQS
EELV
QLVD
ETFC
ZNWAA
MFINL
MSVX
WEYS
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy SRPT

Market Price$163.89
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell SRPT stock and options commission-free.
LearnBlogCareersHelpLog InSign Up